Anthony Burgett

---

Publications & Presentations

6. Burgett A W. Single Cell Mass Spectrometry Quantification of Anticancer Drugs: Proof of Concept in Cancer Patients. ACS Pharmacology and Translational Research . 2021; 4 : 96-100

7. Burgett A. Crystal structures of glutathione- and inhibitor-bound human GGT1: critical interactions within the cysteinylglycine binding site. Journal of Biological Chemistry . 2021; 296 : 100066

8. Burgett A. Indole C6 Functionalization of Tryprostatin B Using Prenyltransferase CdpNPT. Catalysts . 2020; 10

Grants

6. Single Cancer Cell Mass Spectrometry Technology for the Bioanalysis and Effective Drug Treatment of Ovarian Cancer. Intramural Funding. Start Date: 2022. End Date: 2023.

7. Drug Targeting Oxysterol-Binding Protein (OSBP) for Antiviral Treatment of SARS-CoV-2 Infections. Intramural Funding. Start Date: 2022. End Date: 2023.

8. Drug Targeting Oxysterol-Binding Protein (OSBP) for Antiviral Treatment of SARS-CoV-2 Infections. Misc Non-Federal. Start Date: 2022. End Date: 2023.

9. Acquisition of a Campus Sample Concentrator/Lyophilizer for Drug Development and Pharmacology Research. Non-federal. Start Date: 2022. End Date: 2023.

10. Structure/Function of Oxysterol-Binding Protein to Guide Therapeutic Development. NIH. Start Date: 2022. End Date: 2023.

Awards and Honors

1. Susan G. Komen for the Cure Foundation Postdoctoral Fellow. Date: 2007.

Education

1. Degree: Post. Harvard University. Date: 2012.


2. Degree: Ph D. . Date: 2006.


3. Degree: BS. University of Oklahoma. Date: 1999.


4. Degree: BS. University of Oklahoma. Date: 1999.

Administrative Assignments

no results